Inhibition of Topoisomerase II α Subunit De Novo Synthesis by Specific Antisense Oligonucleotides Suppresses Human Glioma T98G Cell Growth

Neurologia Medico-Chirurgica

Volumn 39, Issue 3, 1999, Pages 199-205

  Shin, Masaki ^a   Nagao, Seigo ^a   Kimura, Shoji ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

antisense; glioma; topoisomerase II

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA TOPOISOMERASE (ATP HYDROLYSING);

ALPHA CHAIN; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; DNA REPLICATION; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN SYNTHESIS INHIBITION; SECOND MESSENGER;

EID: 0032950584     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.39.199     Document Type: Article

References (25)

1. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
2. Chen M, Beck WT: Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors Merbarone and VM-26. Cancer Res 55: 1509-1516, 1995.
3. Chow KC, Johnson TL, Person GD: A novel method for the detection and quantitation of eukaryotic topoisomerase I. Biotechniques 3: 290-297, 1985.
4. Downes CS, Clarke DJ, Mullinger AM, Glimenes AJF, Creighton AM, Johnson RT: A topoisomerase II dependent G2 cycle checkpoint in mammalian cells. Nature 372: 467-479, 1994.
5. Drake FH, Hoffman GA, Mong SM, Bartus JO, Hertzberg RP, Johnson RK, Mattern MR, Mirabelli CK: In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. Cancer Res 49: 2578-2583, 1989.
6. Glisson B, Gupta R, Smallwood-Kentro S, Ross W: Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity. Cancer Res 46: 1934-1938, 1986.
7. Hinds M, Deisseroth K, Mayes J, Altschuler E, Jansen R, Ledley FD, Zwelling LA: Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine resistant form of topoisomerase II. Cancer Res 51: 4729-4731, 1991.
8. Holm C, Goto T, Wang JC, Botstein D: DNA topoisomerase II is required at the time of mitosis in yeast. Cell 41: 553-563, 1985.
9. Ishida R, Miki T, Narita T, Yui R, Sato M, Utsumi KR, Tanabe K, Andoh T: Inhibition of intracellular topoisomerase II by antitumor bis(2-6, dioxopiperazine) derivatives; mode of cell growth inhibition distinct from that of cleavable complex, forming type inhibitors. Cancer Res 51: 4909-4916, 1991.
10. Lefevre D, Riou JF, Ahomadegbe JC, Zhou DY, Benard J. Riou G: Study of molecular markers of resistance to mAMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase. Biochem Pharmacol 41: 1967-1979, 1991.
11. Liu LF, Miller KG: Eukaryotic DNA topoisomerases: Two forms of type I DNA topoisomerases from HeLa cell nuclei. Proc Natl Acad Sci U S A 78: 3487-3491, 1981.
12. Madelaine I, Prost S, Naudin A, Riou G, Lavelle F, Riou JF: Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation. Biochem Pharmacol 45: 339-348, 1993.
13. Matsumoto Y, Fujiwara T, Honjo Y, Sasaoka N, Tsuchida T, Nagao S: Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: Characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-II. J Surg Oncol 53: 97-103, 1993.
14. Muller MT, Helal K, Soisson S, Spitzner JR: A rapid and quantitative microtiter assay for eukaryotic topoisomerase II. Nucleic Acids Res 17: 9499, 1989.
15. Muller MT, Spitzner JR, DiDonato JA, Mehta VB, Tsutsui K: Single-strand DNA cleavages by eukaryotic topoisomerase II. Biochemistry 27: 8369-8379, 1988.
16. Nitta T, Sato K: Specific inhibition of c-sis protein synthesis and cell proliferation with antisense oligodeoxynucleotides in human glioma cells. Neurosurgery 34: 309-315, 1994.
17. Nitts JL, Liu YX, Harbury P, Jannatipour M, Wasserman R, Wang JC: Amsacrine and etoposide hypersensitivity of yeast cells overexpression DNA topoisomerase II. Cancer Res 52: 4467-4472, 1992.
18. Sasaoka N: [Chemosensitivity assays for malignant gliomas]. Gan To Kagaku Ryoho 17: 2247-2252, 1990 (Jpn, with Eng abstract).
19. Takano H, Kohno K, Ono M, Uchida Y, Kuwano M: Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer Res 51: 3951-3957, 1991.
20. Tamura H, Kohchi C, Yamada R, Ikeda T, Koiwai O, Patterson E, Keene JD, Okada K, Kjeldsen E, Nishikawa K, Andoh T: Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites. Nucleic Acids Res 19: 69-75, 1991.
21. Tan KB, Mattern MR, Boyce RA, Schein PS: Elevated DNA topoisomerase II activity in nitrogen mustard resistant human cells. Proc Natl Acad Sci U S A 84: 7668-7671, 1987.
22. Tanabe K, Ikegami Y, Ishida R, Andoh T: Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives. Cancer Res 51: 4903-4908, 1991.
23. Tsai-Pflugfeder M, Liu LF, Liu AA, Tewey KM, Whang-Peng J, Knutsen T, Humbner K, Croce CM, Wang JC: Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc Natl Acad Sci, U S A 85: 7177-7181, 1988.
24. Twentyman PR, Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56: 279-285, 1987.
25. Uemura T, Ohkura H, Adachi Y, Morino K, Shiozaki K, Yanagida M: DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell 50: 917-925, 1987.